Invitrox Inc.

Description

Invitrox, Inc., located in Research Park Triangle, North Carolina, is a company dedicated to providing diagnostic and therapeutic assays/drug development services to the pharmaceutical and CRO industries that offer a higher degree of specificity and sensitivity than current methods. Invitrox’s proprietary technology, EQELS, combined with other available methods within our laboratory, compliments the scientific development experience of our corporate team.

The information on this web site is provided by Invitrox which makes no representation or warranty, express or implied, with regard to any information accessed from, or via, this web site or the Internet, including, but not limited to all implied warranties of merchantability, fitness for a particular purpose, or no infringement. Nothing herein shall be construed as conferring a license, be it by implication, estoppels or otherwise, of any right under any patent, trademark, or copyright of Invitrox or any third party. This site also contains third-party information. Wherever practical, in our opinion, such information is marked accordingly. Invitrox does not assume any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product or process disclosed on the web site or other material accessible from the web site. We will continue to make every effort to provide accurate and up-to-date information.

Invitrox has a broad technology platform for developing novel in vitro diagnostic assays and providing unsurpassed professional services in lead optimization and drug development to the pharmaceutical and CRO industry.

Our mission is to develop clinical assays for better lead compound development and monitoring patients with hemostatic, oncologic, or infectious diseases. Invitrox will expand its revenue stream as a diagnostics company based on a portfolio of clinical assays that use a laser Doppler technique to identify and characterize suspended particles, e.g., platelets, circulating tumor cells, nanoparticles, and microbes. Invitrox will serve as a reference lab to pharmaceutical and biotechnology companies for clinical studies with an initial focus on its optimized assays for platelet function testing and anti-coagulant drug assessment.

Fact sheet

Products & services

Similar companies nearby